Isolation and determination of Vibrio spp. pathogen from Sciaenops ocellatus suffering from hemorrhagic disease under cage culture in Vietnam

This study was carried out to isolate and determine the Vibrio spp. from the Red drum fish (Sciaenops ocellatus) suffering from the hemorrhagic disease in Vietnam.  In this study, 18 strains of Vibrio bacteria were identified from 27 samples of Red drum fish. The isolated bacterial strains were identified with the 16S rRNA sequencing method and checked for morphological, physiological, and biochemical characteristics by using the API 20E KIT. Results of the study revealed the presence of twelve strains of V. alginolyticus, three strains of V. fluvialis, and three strains of V. orientalis. All Vibrio strains have gene similarities with those on the Genbank ranging from 98.05 to 100%. The biochemical characteristics of these 18 isolates were similar and these are susceptible to tetracycline and doxycycline and entirely resistant to ampicillin, amoxicillin, and erythromycin

Effects of protein levels of commercial diets on the growth performance and survival rate of rabbitfish (Siganus guttatus) at the nursing stage

This study aimed to determine the effect of a commercial diet's protein level on the fry-to-fingerling stage. Thirty days-old fries having the initial length and weight of 18.25 ± 0.15 mm fish-1 and 0.036 ± 0.50 g fish-1 respectively have been used in this study. Diet having three protein levels i.e. 30% (trial 1 as control), 35% (trial 2), 40% (trial 3), and 45% (trial 4), respectively, have been used to evaluate the effect of protein, and each trial has been repeated three times. During the study, stocking density was allocated to 1000 fish per composite tank with a volume of 1 m3. After 30 days of rearing, the weight of fingerlings in trial 1 reached up to 1.50 ± 0.02 g fish-1 and it was recorded as 1.52 ± 0.01g for trial 2, these two were lower than that of trials 3 and 4, where fingerling weight was reported 1.69 ± 0.01 and 1.58g fish-1 respectively and obtained the best weight compared to others. The length of fingerlings at the end of the experimental period was also changed in different trials and it was recorded 47.12; 46.92; 50.97; and 48.89 mm fish-1 for trail 1, 2, 3, and 4 respectively, among the tested combinations lower fingerlings length was recorded for trial 2 (35% CP), but it is not significantly different for trial 1 and 2 and a significant difference (P < 0.05) was reported for trail 2, 3, and 4. The survival rate of fingerlings ranged from 67.27 to 72.33%. Meanwhile, the herd distribution coefficient variation (CVW) in the treatment using 40% protein (trial 3) was the highest at 72.33% (p < 0.05). The results of the study can be concluded that the level of protein has a significant effect on the various growth parameters of fingerlings

Heterogeneity of pathological prion protein accumulation in the brain of moose (<i>Alces alces</i>) from Norway, Sweden and Finland with chronic wasting disease

Prion diseases are a group of neurodegenerative, transmissible, and fatal disorders that affect several animal species. They are characterized by the conformational conversion of the cellular prion protein (PrPC) into the pathological prion protein (PrPSc). In 2016, chronic wasting disease (CWD) gained great importance at European level due to the first disease detection in a wild reindeer (Rangifer tarandus) in Norway. The subsequent intensive CWD surveillance launched in cervids resulted in the detection of CWD in moose (Alces alces), with 11 cases in Norway, 3 in Finland and 4 in Sweden. These moose cases differ considerably from CWD cases in North American and reindeer in Norway, as PrPSc was detectable in the brain but not in lymphoid tissues. These facts suggest the occurrence of a new type of CWD. Here, we show some immunohistochemical features that are clearly different from CWD cases in North American and Norwegian reindeer. Further, the different types of PrPSc deposits found among moose demonstrate strong variations between the cases, supporting the postulation that these cases could carry multiple strains of CWD

HỢP CHẤT STEROID VÀ FLAVONE TỪ THÂN RỄ THIÊN NIÊN KIỆN LÁ LỚN (Homalomena pendula)

Phytochemical investigation of the rhizomes of Homalomena pendula resulted in the isolation of one flavone and three steroids. These compounds were determined as tangeretin (1), ergosterol peroxide (2), sitoindoside I (3), and stigmasterol (4) on the basis of 1D and 2D NMR data and in comparison with the available data in the literature. Compounds 1‒3 were found for the first time from the genus Homamomena. The n-hexane and ethyl acetate extracts show NO production inhibitory activity in RAW 264.7 macrophage cells with IC50 values of 46.8 and 75.52 µg·mL–1.Hợp chất flavone, tangeretin (1), và ba hợp chất steroid: ergosterol peroxide (2), sitoindoside I (3) và stigmasterol (4) đã được phân lập từ thân rễ của cây thiên niên kiện lá lớn (Homalomena pendula). Cấu trúc hóa học của chúng được xác định dựa trên phân tích dữ liệu phổ cộng hưởng từ hạt nhân (1D và 2D NMR) và so sánh với các tài liệu đã công bố. Các hợp chất (1-3) được phân lập lần đầu tiên từ chi Homalomena. Cao chiết n-hexane và ethyl acetate của cây này có hoạt tính ức chế sản sinh NO trên đại thực bào RAW 264.7 kích thích bằng lipopolysaccharide với các giá trị IC50 là 46,80 và 75,52 µg·mL–1

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke

Making distributed edge machine learning for resource-constrained communities and environments smarter: contexts and challenges

Publisher Copyright: © 2022, The Author(s).The maturity of machine learning (ML) development and the decreasing deployment cost of capable edge devices have proliferated the development and deployment of edge ML solutions for critical IoT-based business applications. The combination of edge computing and ML not only addresses the development cost barrier, but also solves the obstacles due to the lack of powerful cloud data centers. However, not only the edge ML research and development is still at an early stage and requires substantial skills normally missed in resource-constrained communities, but also various infrastructure constraints w.r.t. network reliability and computing power, and business contexts from the resource-constrained environments require different considerations to make edge ML applications context aware through smart and intelligent runtime strategies. In this paper, we analyze representative real-world business scenarios for edge ML solutions and their contexts in resource-constrained communities and environments. We identify andmap the key distinguished contexts of distributed edge ML and discuss the impacts of these contexts on data and software components and deployment models. Finally, we present key research areas, how we should approach them, and possible tooling for making edge machine learning solutions smarter in resource-constrained communities and environments.Peer reviewe

MAppGraph: Mobile-App Classification on Encrypted Network Traffic using Deep Graph Convolution Neural Networks

Identifying mobile apps based on network traffic has multiple benefits for security and network management. However, it is a challenging task due to multiple reasons. First, network traffic is encrypted using an end-to-end encryption mechanism to protect data privacy. Second, user behavior changes dynamically when using different functionalities of mobile apps. Third, it is hard to differentiate traffic behavior due to common shared libraries and content delivery within modern mobile apps. Existing techniques managed to address the encryption issue but not the others, thus achieving low detection/classification accuracy. In this paper, we present MAppGraph, a novel technique to classify mobile apps, addressing all the above issues. Given a chunk of traffic generated by an app, MAppGraph constructs a communication graph whose nodes are defined by tuples of IP address and port of the services connected by the app, edges are established by the weighted communication correlation among the nodes. We extract information from packet headers without analyzing encrypted payload to form feature vectors of the nodes. We leverage deep graph convolution neural networks to learn the diverse communication behavior of mobile apps from a large number of graphs and achieve a fast classification. To validate our technique, we collect traffic of a hundred mobile apps on the Android platform and run extensive experiments with various experimental scenarios. The results show that MAppGraph significantly improves classification accuracy by up to 20% compared to recently developed techniques and demonstrates its practicality for security and network management of mobile services.Peer reviewe

Inter- and intra-species conversion efficacies of Norwegian prion isolates estimated by serial protein misfolding cyclic amplification

Abstract Prion diseases, including chronic wasting disease (CWD) in cervids, are fatal neurodegenerative disorders caused by the misfolding of cellular prion proteins. CWD is known to spread among captive and free-ranging deer in North America. In 2016, an outbreak of contagious CWD was detected among wild reindeer in Norway, marking the first occurrence of the disease in Europe. Additionally, new sporadic forms of CWD have been discovered in red deer in Norway and moose in Fennoscandia. We used serial protein misfolding cyclic amplification to study the ability of Norwegian prion isolates from reindeer, red deer, and moose (two isolates), as well as experimental classical scrapie from sheep, to convert a panel of 16 brain homogenates (substrates) from six different species with various prion protein genotypes. The reindeer CWD isolate successfully converted substrates from all species except goats. The red deer isolate failed to convert sheep and goat substrates but exhibited amplification in all cervid substrates. The two moose isolates demonstrated lower conversion efficacies. The wild type isolate propagated in all moose substrates and in the wild type red deer substrate, while the other isolate only converted two of the moose substrates. The experimental classical scrapie isolate was successfully propagated in substrates from all species tested. Thus, reindeer CWD and classical sheep scrapie isolates were similarly propagated in substrates from different species, suggesting the potential for spillover of these contagious diseases. Furthermore, the roe deer substrate supported conversion of three isolates suggesting that this species may be vulnerable to prion disease

Deposit insurance and credit union lending

We exploit an exogenous change in the coverage of insured deposits following the passage of the Emergency Economic Stabilization Act (2008) to investigate the impact of deposit insurance on the volume, composition and quality of credit union lending. Using a difference-in-difference approach, we find changes in the volume, composition and riskiness of credit union lending. Specifically, we find that affected credit unions increase total and unsecured lending, leading to a decline in loan quality. Overall, our results suggest that an increase in the maximum coverage of insured deposits induces credit unions to lend more at the expense of loan quality.PostprintPeer reviewe

Goats naturally devoid of PrPC are resistant to scrapie

Prion diseases are progressive and fatal, neurodegenerative disorders described in humans and animals. According to the "protein-only" hypothesis, the normal host-encoded prion protein (PrPC) is converted into a pathological and infectious form (PrPSc) in these diseases. Transgenic knockout models have shown that PrPC is a prerequisite for the development of prion disease. In Norwegian dairy goats, a mutation (Ter) in the prion protein gene (PRNP) effectively blocks PrPC synthesis. We inoculated 12 goats (4 PRNP+/+, 4 PRNP+/Ter, and 4 PRNPTer/Ter) intracerebrally with goat scrapie prions. The mean incubation time until clinical signs of prion disease was 601 days post-inoculation (dpi) in PRNP+/+ goats and 773 dpi in PRNP+/Ter goats. PrPSc and vacuolation were similarly distributed in the central nervous system (CNS) of both groups and observed in all brain regions and segments of the spinal cord. Generally, accumulation of PrPSc was limited in peripheral organs, but all PRNP+/+ goats and 1 of 4 PRNP+/Ter goats were positive in head lymph nodes. The four PRNPTer/Ter goats remained healthy, without clinical signs of prion disease, and were euthanized 1260 dpi. As expected, no accumulation of PrPSc was observed in the CNS or peripheral tissues of this group, as assessed by immunohistochemistry, enzyme immunoassay, and real-time quaking-induced conversion. Our study shows for the first time that animals devoid of PrPC due to a natural mutation do not propagate prions and are resistant to scrapie. Clinical onset of disease is delayed in heterozygous goats expressing about 50% of PrPC levels.publishedVersio